Returning to Washington, DC this September, the PDA/FDA Joint Regulatory Conference 2026 remains the pharmaceutical industry’s most trusted forum for open, informed dialogue between global regulators and industry professionals. For more than three decades, this event delivers critical insights to strengthen compliance, advance quality systems, and protect patients worldwide.

This premier CGMP conference spotlights the role of effective quality systems in maintaining an ongoing state of control across the product lifecycle through vigilant risk-based manufacturing and quality oversight. The conference underscores the vital role of robust quality systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management as the foundation of CGMP compliance. Through real-world case studies, participants gain practical, actionable insights into how sustainable compliance drives both quality excellence and supply consistency. International regulatory collaboration efforts to improve quality and benefit consumers will also be featured.

Now more than ever, don’t miss your chance to engage directly with regulators and peers, gain practical tools, and stay ahead of evolving expectations at the industry’s leading regulatory event.

Extend Your Learning: Maximize your time in DC with the post‑conference PDA Data Governance Workshop 2026.